22 results
8-K
EX-99.2
RLAY
Relay Therapeutics Inc
8 Aug 23
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:14pm
(Separate CEO and Chair Role) 88% The Nom/Gov and Audit Committees oversee ESG efforts, with the full BOD getting ~quarterly updates 8 Directors Total
PRE 14A
ks7tf82c
1 Apr 22
Preliminary proxy
4:30pm
DEF 14A
b44maoev
7 Apr 21
Definitive proxy
4:16pm
10-K
EX-10.10
mr9t8 zshug5bg6aan
25 Mar 21
Annual report
4:31pm
10-K
uwm1ex f51fq9
25 Mar 21
Annual report
4:31pm
424B4
u06bg11hh2979iicrugp
16 Jul 20
Prospectus supplement with pricing info
4:34pm
S-1/A
h7y2q eq08gxlds
9 Jul 20
IPO registration (amended)
7:17am
S-1
EX-10.7
yhw6 4yz9t
24 Jun 20
IPO registration
5:03pm
S-1
4gcdaoe
24 Jun 20
IPO registration
5:03pm
S-1
EX-10.10
kge9v srspel416
24 Jun 20
IPO registration
5:03pm
DRS/A
EX-10.10
3wnygrf96b6
22 Jun 20
Draft registration statement (amended)
12:00am
DRS
vfqima2x0z9y39 en4
22 May 20
Draft registration statement
12:00am